56 related articles for article (PubMed ID: 38662451)
1. Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study).
Napoléon B; Lisotti A; Caillol F; Gasmi M; Ah-Soune P; Belle A; Charachon A; Cholet F; Eyraud PY; Grandval P; Gonzalez JM; Habersetzer F; Koch S; Le Rhun M; Mangialavori L; Musquer N; Palazzo M; Poincloux L; Privat J; Sportes A; Stouvenot M; Subtil C; Thomassin L; Vanbiervliet G; Vidal G; Vuitton L; Giovannini M; Barthet M
Gastrointest Endosc; 2023 Sep; 98(3):392-399.e1. PubMed ID: 37059368
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic ultrasound-guided radiofrequency ablation of premalignant pancreatic-cystic neoplasms and neuroendocrine tumors: prospective study.
Younis F; Ben-Ami Shor D; Lubezky N; Geva R; Osher E; Shibolet O; Phillips A; Scapa E
Eur J Gastroenterol Hepatol; 2022 Nov; 34(11):1111-1115. PubMed ID: 36170679
[TBL] [Abstract][Full Text] [Related]
3. Management of non-functional pancreatic neuroendocrine tumors by endoscopic ultrasound-guided radiofrequency ablation: Retrospective study in two tertiary centers.
Marx M; Godat S; Caillol F; Poizat F; Ratone JP; Pesenti C; Schoepfer A; Hoibian S; Dahel Y; Giovannini M
Dig Endosc; 2022 Sep; 34(6):1207-1213. PubMed ID: 34963025
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors.
Pai M; Habib N; Senturk H; Lakhtakia S; Reddy N; Cicinnati VR; Kaba I; Beckebaum S; Drymousis P; Kahaleh M; Brugge W
World J Gastrointest Surg; 2015 Apr; 7(4):52-9. PubMed ID: 25914783
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic tumors.
Patel V; Abdelbaki A; Thosani NC; Krishna SG
Curr Opin Gastroenterol; 2024 Apr; ():. PubMed ID: 38662451
[TBL] [Abstract][Full Text] [Related]
6. A Review on Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of Pancreatic Lesions.
Karaisz FG; Elkelany OO; Davies B; Lozanski G; Krishna SG
Diagnostics (Basel); 2023 Feb; 13(3):. PubMed ID: 36766643
[TBL] [Abstract][Full Text] [Related]
7. EUS-RFA of the pancreas: where are we and future directions.
Gollapudi LA; Tyberg A
Transl Gastroenterol Hepatol; 2022; 7():18. PubMed ID: 35548478
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic Ultrasound-Guided Local Ablative Therapies for the Treatment of Pancreatic Neuroendocrine Tumors and Cystic Lesions: A Review of the Current Literature.
Prete AM; Gonda TA
J Clin Med; 2023 May; 12(9):. PubMed ID: 37176764
[TBL] [Abstract][Full Text] [Related]
9. An update on EUS-guided ablative techniques for pancreatic cystic lesions.
Ardeshna DR; Woods E; Tsung A; Krishna SG
Endosc Ultrasound; 2022; 11(6):432-441. PubMed ID: 35313421
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic insulinoma: a state of the art review.
Dhar J; Samanta J; Nabi Z; Aggarwal M; Facciorusso A; Conti Bellocchi MC; Crinò SF
Expert Rev Gastroenterol Hepatol; 2024; 18(1-3):37-53. PubMed ID: 38383965
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
